Company intelligence / Profile preview

PrecisionMed

Carlsbad, California, United States

Ownership: Private
Employees: ~106
Development stage: Other

Overview

PrecisionMed operates the world's largest private, longitudinally collected human CSF biobank, featuring over 170,000 biospecimens with matched clinical data. Their samples have supported >600 pharma/biotech/academic organizations, have >120 literature citations, and have contributed to FDA-cleared diagnostics.

Therapeutic areas: OncologyNeurologyOther
Modalities: Human biospecimens (CSF, plasma, serum, whole blood, DNA, RNA, PBMCs, tissue, urine)
Industry: Non-Drug Biotech

Partnerships

Academic research organizations>600 pharmaceutical and biotech companies (example partners cited: Biogen, GlaxoSmithKline, Harvard Medical School)

Beyond the preview

Go deeper on PrecisionMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrecisionMed.

Explore the full profile